Breakthrough Research in Cancer Therapy Outcomes for Medicare Patients
Explore groundbreaking cancer therapy outcomes for Medicare patients, highlighting pivotal studies on leukemia, lymphoma, and innovative treatments.
Explore groundbreaking cancer therapy outcomes for Medicare patients, highlighting pivotal studies on leukemia, lymphoma, and innovative treatments.
Fujitsu and Daiichi Life launch a research initiative exploring quantum tech in insurance to enhance asset management strategies. Discover innovative solutions now.
Explore the Federal Reserve's critical role in shaping monetary policy and ensuring financial stability in the U.S. economy.
Explore the latest advancements in psychedelic treatments and their regulatory implications, alongside important insights on Medicare fraud and healthcare safety.
Discover a rise in CGM adoption among Medicare enrollees with diabetes, enhancing management and access by 2026 with no out-of-pocket costs.
A new study reveals a sharp rise in aspergillosis diagnoses in the U.S., highlighting the need for improved health access and fungal disease surveillance.
Explore the $3M Medicare Advantage study examining non-medical benefits like food aid and transportation, assessing their effects on health outcomes and emergency visits.
A groundbreaking study showcases stem cell-derived treatment for type 2 diabetes, potentially revolutionizing insulin production and diabetes management.
ATRI's 2025 research priorities focus on rising insurance costs, driver training impacts, safety tech, telematics, and cabotage violations in U.S. trucking.